Therapy in patients at high risk for atherosclerotic cardiovascular disease -: From biological efficacy to disappointing clinical outcomes

被引：0
|
作者：
Fainaru, M [1 ]
机构：
[1] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel
来源：
FREE RADICAL BIOLOGY AND MEDICINE | 2002年 / 33卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
487
引用
收藏
页码：S186 / S186
页数：1
相关论文
共 50 条
  • [1] Clinical potential of inclisiran for patients with a high risk of atherosclerotic cardiovascular disease
    Toshiyuki Nishikido
    Cardiovascular Diabetology, 22
  • [2] Clinical potential of inclisiran for patients with a high risk of atherosclerotic cardiovascular disease
    Nishikido, Toshiyuki
    CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [3] Current Guideline Risk Stratification and Cardiovascular Outcomes in Chinese Patients Suffered From Atherosclerotic Cardiovascular Disease
    Li, Sha
    Liu, Hui-Hui
    Guo, Yuan-Lin
    Zhu, Cheng-Gang
    Wu, Na-Qiong
    Xu, Rui-Xia
    Dong, Qian
    Qian, Jie
    Dou, Ke-Fei
    Li, Jian-Jun
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [4] Outcome of pitavastatin versus atorvastatin therapy in patients with hypercholesterolemia at high risk for atherosclerotic cardiovascular disease
    Moroi, Masao
    Nagayama, Daiji
    Hara, Fumihiko
    Saiki, Atsuhito
    Shimizu, Kazuhiro
    Takahashi, Mao
    Sato, Naoko
    Shiba, Teruo
    Sugimoto, Hideki
    Fujioka, Toshiki
    Chiba, Tatsuo
    Nishizawa, Kosuke
    Usui, Shuki
    Iwasaki, Yasuo
    Tatsuno, Ichiro
    Sugi, Kaoru
    Yamasaki, Junichi
    Yamamura, Shigeo
    Shirai, Kohji
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2020, 305 : 139 - 146
  • [5] PCSK9 inhibition and clinical cardiovascular outcomes in patients with atherosclerotic cardiovascular disease
    Landmesser, Ulf
    CARDIOVASCULAR RESEARCH, 2017, 113 (08) : E24 - E25
  • [6] Atherosclerotic cardiovascular disease and heart failure: Determinants of risk and outcomes in patients with diabetes
    Nelson, Adam J.
    Peterson, Eric D.
    Pagidipati, Neha J.
    PROGRESS IN CARDIOVASCULAR DISEASES, 2019, 62 (04) : 306 - 314
  • [7] Combination therapy in patients with atherosclerotic cardiovascular disease
    Laffman-Johnson, Elise
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 (02) : 159 - 159
  • [8] Clinical outcomes by atherosclerotic cardiovascular disease risk score and blood pressure level in high risk individuals with type 2 diabetes
    Katie Harris
    Paul Muntner
    Mark Woodward
    Min Jun
    Megumi Oshima
    Jessica Gong
    Stephen Harrap
    Joel Menard
    John Chalmers
    Journal of Human Hypertension, 2023, 37 : 181 - 188
  • [9] Efficacy and Safety of Lerodalcibep in Patients With or at High Risk of Cardiovascular Disease A Randomized Clinical Trial
    Klug, Eric Q.
    Llerena, Sara
    Burgess, Lesley J.
    Fourie, Nyda
    Scott, Russell
    Vest, Jeff
    Caldwell, Kate
    Kallend, David
    Stein, Evan A.
    JAMA CARDIOLOGY, 2024,
  • [10] Clinical outcomes by atherosclerotic cardiovascular disease risk score and blood pressure level in high risk individuals with type 2 diabetes
    Harris, Katie
    Muntner, Paul
    Woodward, Mark
    Jun, Min
    Oshima, Megumi
    Gong, Jessica
    Harrap, Stephen
    Menard, Joel
    Chalmers, John
    JOURNAL OF HUMAN HYPERTENSION, 2023, 37 (03) : 181 - 188
12345